TMO Thermo Fisher Scientific Inc Common Stock
$513,11
Kurs · Jun 26, 2026
Fundamentaldaten per Mai 1, 2026
52W-Spanne
$401–$644
46% of range
Analystenbewertung
BUY
34 analysts
Kursziel
$599
+17% upside
P/E (TTM)
32.7
ROE
13.0%
Nettogewinnmarge
15.0%
TMO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$513.11
Marktkapitalisierung
$257.86B
P/E (TTM)
32.7
EPS (TTM)
$17.74
Umsatz (TTM)
$44.56B
Dividendenrendite
0.25%
ROE
13.0%
Verschuldungsgrad
—
52W-Spanne
$401 – $644
TMO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$44.56B
2020-12-31
→
2025-12-31
EPS
$17.74
2020-12-31
→
2025-12-31
Freier Cashflow
$6.29B
2020-12-31
→
2025-12-31
Margen
15.0%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
TMO
Peer-Median
P/E (TTM)
32.7
18.0
P/S (TTM) (K/V (TTM))
5.8
3.3
P/B (K/B)
4.8
1.6
Price / FCF (Kurs / FCF)
41.0
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
TMO
Peer-Median
Operating Margin (Betriebsgewinnmarge)
17.4%
—
Net Profit Margin (Nettogewinnmarge)
15.0%
-21.2%
ROA
6.5%
-8.2%
ROE
13.0%
-10.6%
ROIC
13.4%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
TMO
Peer-Median
Current Ratio (Liquiditätsgrad)
1.9
4.9
Quick Ratio
1.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
TMO
Peer-Median
Revenue YoY (Umsatz YoY)
3.9%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-0.27%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
6.7%
—
EPS YoY (EPS VjV)
7.3%
—
Net Income YoY (Nettogewinn YoY)
5.8%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
TMO
Peer-Median
Payout Ratio (Ausschüttungsquote)
9.5%
—
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
0.25%
Ausschüttungsquote
9.5%
5J Div CAGR
—
| Ex-Datum | Betrag |
|---|---|
| 15. Juni 2026 | $0,4700 |
| 13. März 2026 | $0,4700 |
| 15. Dezember 2025 | $0,4300 |
| 15. September 2025 | $0,4300 |
| 13. Juni 2025 | $0,4300 |
| 14. März 2025 | $0,4300 |
| 13. Dezember 2024 | $0,3900 |
| 13. September 2024 | $0,3900 |
| 14. Juni 2024 | $0,3900 |
| 14. März 2024 | $0,3900 |
| 14. Dezember 2023 | $0,3500 |
| 14. September 2023 | $0,3500 |
| 14. Juni 2023 | $0,3500 |
| 14. März 2023 | $0,3500 |
| 14. Dezember 2022 | $0,3000 |
| 14. September 2022 | $0,3000 |
| 14. Juni 2022 | $0,3000 |
| 15. März 2022 | $0,3000 |
| 14. Dezember 2021 | $0,2600 |
| 14. September 2021 | $0,2600 |
TMO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
34 Analysten
- Starker Kauf 11 32,4%
- Kauf 18 52,9%
- Halten 5 14,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
26 Analysten · 2026-06-26
Median
$600.00
Jetzt
$513.11
Tief
$490.00
Hoch
$750.00
Median-Ziel
$600.00
+16,9%
Mittelwert-Ziel
$599.19
+16,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.11%
Nächster Bericht
Jul 21, 2026
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $5.44 | $5.29 | 0.15% |
| 31. Dezember 2025 | $6.57 | $6.51 | 0.06% |
| 30. September 2025 | $5.79 | $5.55 | 0.24% |
| 30. Juni 2025 | $5.36 | $5.28 | 0.08% |
| 31. März 2025 | $5.15 | $5.15 | -0.00% |
Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B | $32.22B | $25.54B | $24.36B | · | $20.92B | $18.27B | $16.96B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | $8.98B | $8.21B | $7.58B | |
| R&D Expense | $1.40B | $1.39B | $1.34B | $1.47B | $1.41B | $1.18B | $1.00B | $967M | · | $887M | $754M | $692M | |
| SG&A Expense | $8.73B | $8.60B | $8.45B | $8.99B | $8.01B | $6.93B | $6.14B | $6.06B | · | $5.50B | $4.97B | $4.61B | |
| Operating Expenses | $36.81B | $35.54B | $36.00B | $36.52B | $29.18B | $24.42B | $20.95B | $20.57B | · | $17.96B | $15.82B | $14.63B | |
| Operating Income | $7.75B | $7.34B | $6.86B | $8.39B | $10.03B | $7.79B | $4.59B | $3.78B | · | $2.96B | $2.46B | $2.34B | |
| Interest Expense | · | · | $1.38B | $726M | $536M | $553M | $676M | $667M | · | $592M | $469M | $415M | |
| Interest Income | $993M | $1.08B | $879M | $272M | $43M | $65M | $224M | $137M | · | $81M | $48M | $31M | |
| Other Non-op | $-12M | $12M | $-65M | $-104M | $-694M | $-76M | $-70M | $9M | · | $-20M | $-13M | $-16M | |
| Pretax Income | $7.31B | $7.04B | $6.30B | $7.83B | $8.84B | $7.23B | $4.07B | $3.26B | · | $2.43B | $2.02B | $1.94B | |
| Income Tax | $547M | $657M | $284M | $703M | $1.11B | $850M | $374M | $324M | · | $201M | $-1M | $-44M | |
| Net Income | $6.70B | $6.33B | $6.00B | $6.96B | $7.73B | $6.38B | $3.70B | · | · | · | · | · | |
| EPS (Basic) | $17.77 | $16.58 | $15.52 | $17.75 | $19.62 | $16.09 | $9.24 | $7.31 | · | $5.64 | $5.12 | $4.96 | |
| EPS (Diluted) | $17.74 | $16.53 | $15.45 | $17.63 | $19.46 | $15.96 | $9.17 | $7.24 | · | $5.59 | $5.09 | $4.92 | |
| Shares (Basic) | 377,000,000 | 382,000,000 | 386,000,000 | 392,000,000 | 394,000,000 | 396,000,000 | 400,000,000 | 402,000,000 | · | 395,000,000 | 395,000,000 | 399,000,000 | |
| Shares (Diluted) | 378,000,000 | 383,000,000 | 388,000,000 | 394,000,000 | 397,000,000 | 399,000,000 | 403,000,000 | 406,000,000 | · | 398,000,000 | 397,000,000 | 402,000,000 | |
| EBITDA | $7.75B | $7.34B | $6.86B | $8.39B | $10.03B | $7.79B | $4.59B | $6.05B | · | $5.00B | $4.21B | $4.02B |
Bilanz 28
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.85B | $4.01B | $8.08B | $8.52B | $4.48B | $10.32B | $2.40B | $2.10B | · | $1.33B | $786M | $452M | |
| Short-term Investments | $253M | $1.56B | $3M | · | · | · | · | · | · | · | · | · | |
| Receivables | $8.90B | $8.19B | $8.22B | $8.12B | $7.98B | $5.74B | $4.35B | $4.14B | $3.87B | $3.88B | $3.05B | $2.54B | |
| Inventory | $5.42B | $4.98B | $5.09B | $5.63B | $5.05B | $4.03B | $3.37B | $3.00B | $2.72B | $2.97B | $2.21B | $1.99B | |
| Other Current Assets | $2.61B | $1.96B | $1.76B | $1.64B | $1.64B | $1.13B | $1.17B | $922M | $1.47B | $1.24B | $595M | $534M | |
| Current Assets | $28.71B | $22.14B | $24.59B | $25.23B | $20.11B | $21.96B | $11.89B | $10.62B | · | $9.42B | $7.02B | $5.74B | |
| PP&E (Net) | $10.56B | $9.31B | $9.45B | $9.28B | $8.33B | $5.91B | $4.75B | $4.17B | · | $4.05B | $2.58B | $2.45B | |
| PP&E (Gross) | $18.38B | $16.06B | $15.52B | $14.27B | $12.59B | $9.58B | $7.76B | $6.82B | · | $6.34B | $4.42B | $4.11B | |
| Accum. Depreciation | $7.82B | $6.75B | $6.08B | $4.99B | $4.26B | $3.67B | $3.02B | $2.65B | · | $2.29B | $1.84B | $1.66B | |
| Goodwill | $49.36B | $45.85B | $44.02B | $41.20B | $41.92B | $26.04B | $25.71B | $25.35B | · | $25.29B | $21.33B | $18.83B | |
| Intangibles | $15.84B | $15.53B | $16.67B | $17.44B | $20.11B | $12.69B | $14.01B | $14.98B | · | $16.68B | $13.97B | $12.76B | |
| Other Non-current Assets | $5.87B | $4.49B | $4.00B | $4.01B | $4.64B | $2.46B | $2.01B | $1.12B | $1.17B | $1.23B | $1.01B | $1.06B | |
| Total Assets | $110.34B | $97.32B | $98.73B | $97.15B | $95.12B | $69.05B | $58.38B | $56.23B | · | $56.67B | $45.91B | $40.83B | |
| Accounts Payable | $3.62B | $3.08B | $2.87B | $3.38B | $2.87B | $2.17B | $1.92B | $1.61B | · | $1.43B | $926M | $822M | |
| Short-term Debt | · | · | · | · | · | · | · | $693M | · | $960M | $953M | $50M | |
| Current Liabilities | $15.19B | $13.33B | $14.01B | $17.01B | $13.44B | $10.30B | $6.20B | $6.15B | · | $7.05B | $4.87B | $4.15B | |
| Capital Leases | $1.20B | $1.24B | $1.24B | $1.31B | $1.20B | $626M | $571M | · | · | · | · | · | |
| Deferred Tax | $1.49B | $1.27B | $1.92B | $2.85B | $3.84B | $1.79B | $2.19B | $2.27B | $2.71B | $2.77B | $2.56B | $2.62B | |
| Other Non-current Liabilities | $4.27B | $3.99B | $4.64B | $4.24B | $4.54B | $3.33B | $3.24B | $2.52B | $2.64B | $2.57B | $1.57B | $1.29B | |
| Long-term Debt | $39.17B | $31.07B | $34.73B | $34.28B | $34.67B | $21.73B | $17.75B | $18.99B | · | · | · | · | |
| Total Debt | · | · | · | · | · | $19.11B | $17.08B | $693M | · | $960M | $953M | $50M | |
| Common Stock | $445M | $444M | $442M | $441M | $439M | $437M | $434M | $432M | · | $428M | $415M | $412M | |
| Retained Earnings | $59.16B | $53.10B | $47.36B | $41.91B | $35.43B | $28.12B | $22.09B | $18.70B | $16.03B | $15.91B | $13.93B | $12.14B | |
| Treasury Stock | $22.31B | $19.23B | $15.13B | $12.02B | $8.92B | $6.82B | $5.24B | $3.67B | · | $3.10B | $2.31B | $1.01B | |
| AOCI | $-2.45B | $-2.70B | $-3.22B | $-3.10B | $-2.33B | $-2.81B | $-2.68B | $-2.50B | $-2.09B | $-2.00B | $-2.64B | $-2.00B | |
| Stockholders' Equity | $53.41B | $49.58B | $46.73B | $43.98B | $40.79B | $34.51B | $29.68B | $27.59B | · | $25.41B | $21.54B | $21.35B | |
| Liabilities + Equity | $110.34B | $97.32B | $98.73B | $97.15B | $95.12B | $69.05B | $58.38B | $56.23B | · | $56.67B | $45.91B | $40.83B | |
| Shares Outstanding | 445,000,000 | 444,000,000 | 442,000,000 | 441,000,000 | 439,000,000 | 437,000,000 | 434,000,000 | · | · | · | · | · |
Cashflow 19
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $2.27B | · | $2.03B | $1.76B | $1.69B | |
| Stock-based Comp | $310M | $301M | $278M | $307M | $230M | $196M | $181M | $181M | · | $159M | $133M | $125M | |
| Deferred Tax | $-639M | $-1.21B | $-1.30B | $-997M | $-645M | $-269M | $-499M | $-474M | · | $-1.70B | $-639M | $-600M | |
| Amort. of Intangibles | $1.73B | $1.95B | $2.34B | $2.40B | $1.76B | $1.67B | $1.71B | $1.74B | · | $1.59B | $1.38B | $1.31B | |
| Restructuring | $197M | $97M | $194M | $68M | $37M | $51M | $52M | $88M | · | $106M | $167M | $90M | |
| Operating Cash Flow | $7.82B | $8.67B | $8.41B | $9.15B | $9.31B | $8.29B | $4.97B | $4.54B | · | $4.00B | $3.26B | $2.94B | |
| CapEx | $1.52B | $1.40B | $1.48B | $2.24B | $2.52B | $1.47B | $926M | $758M | · | $508M | $444M | $423M | |
| Investing Cash Flow | $-4.05B | $-5.84B | $-5.14B | $-2.16B | $-21.93B | $-1.51B | $-1.49B | $-1.25B | · | $-7.73B | $-5.52B | $-1.09B | |
| Debt Issued | $7.76B | $1.20B | $5.94B | $3.19B | $18.14B | $3.46B | $5.64B | $690M | · | $6.46B | $7.60B | $1.80B | |
| Net Debt Issued | $5.35B | $-2.40B | $160M | $2.82B | $6.40B | $2.75B | $-722M | $-1.36B | · | $3.16B | $3.27B | $-1.98B | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | $1.69B | $0 | $0 | |
| Stock Repurchased | $3.00B | $4.00B | $3.00B | $3.00B | $2.00B | $1.50B | $1.50B | $500M | · | $750M | $1.25B | $500M | |
| Net Stock Activity | $-3.00B | $-4.00B | $-3.00B | $-3.00B | $-2.00B | $-1.50B | $-1.50B | $-500M | · | $940M | $-1.25B | $-500M | |
| Dividends Paid | $636M | $583M | $523M | $455M | $395M | $337M | $297M | $266M | · | $237M | $238M | $241M | |
| Financing Cash Flow | $1.80B | $-6.79B | $-3.62B | $-2.81B | $6.58B | $959M | $-3.12B | $-2.24B | · | $3.85B | $2.76B | $-2.62B | |
| Net Change in Cash | $5.84B | $-4.06B | $-440M | $4.05B | $-5.84B | $7.91B | $305M | $756M | · | $550M | $345M | $-898M | |
| Taxes Paid | $1.78B | $1.83B | $1.48B | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $6.29B | $7.27B | $6.93B | $6.91B | $6.79B | $6.82B | $4.05B | $3.79B | · | $3.50B | $2.71B | $2.39B | |
| Levered FCF | · | · | $5.61B | $6.25B | $6.32B | $6.33B | $3.43B | $3.18B | · | $2.95B | $2.24B | $1.97B |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.4% | 17.1% | 16.0% | 18.7% | 25.6% | 24.2% | 18.0% | 15.5% | · | 14.2% | 13.4% | 13.8% | |
| Net Margin | 15.0% | 14.8% | 13.9% | 15.5% | 19.7% | · | · | · | · | · | · | · | |
| Pretax Margin | 16.4% | 16.4% | 14.7% | 17.4% | 22.6% | 22.4% | 15.9% | 13.4% | · | 11.6% | 11.1% | 11.4% | |
| EBITDA Margin | 17.4% | 17.1% | 16.0% | 18.7% | 25.6% | 24.2% | 18.0% | 24.8% | · | 23.9% | 23.0% | 23.7% | |
| ROA | 6.5% | 6.4% | 6.1% | 7.2% | 9.4% | · | · | · | · | · | · | · | |
| ROE | 13.0% | 13.2% | 13.1% | 16.4% | 19.9% | · | · | · | · | · | · | · | |
| ROIC | 13.4% | 13.4% | 14.0% | 17.4% | 21.5% | 12.8% | 8.9% | 12.0% | · | 10.3% | 10.9% | 11.2% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.7 | 1.8 | 1.5 | 1.5 | 2.1 | 1.9 | 1.7 | · | 1.3 | 1.4 | 1.4 | |
| Quick Ratio | 1.3 | 1.0 | 1.2 | 1.0 | 0.9 | 1.6 | 1.1 | 1.0 | · | 0.7 | 0.8 | 0.7 | |
| Debt / Equity | · | · | · | · | · | 0.6 | 0.6 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | 0.6 | 0.6 | · | · | · | · | · | |
| Interest Coverage | · | · | 5.0 | 11.6 | 18.7 | 14.1 | 6.8 | 5.7 | · | 5.0 | 5.2 | 5.6 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | 3.5 | 3.9 | 3.9 | |
| Receivables Turnover | 5.2 | 5.2 | 5.2 | 5.6 | 5.7 | 6.4 | 6.0 | 6.1 | · | 6.0 | 6.5 | 6.8 |
Wachstumsraten 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.9% | 0.05% | -4.6% | 14.5% | 21.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.27% | 3.0% | 10.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.3% | 7.0% | -12.4% | -9.4% | 21.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 0.21% | -5.3% | -1.1% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 2.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 5.8% | 5.7% | -13.9% | -9.9% | 21.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -1.2% | -6.4% | -2.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 1.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 13.5% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B | $32.22B | $25.54B | $24.36B | · | $20.92B | $18.27B | $16.96B | |
| Net Income TTM | $6.70B | $6.33B | $6.00B | $6.96B | $7.73B | $6.38B | $3.70B | $1.48B | · | $1.48B | $1.48B | $1.48B | |
| Market Cap | $257.86B | $230.98B | $234.61B | $242.85B | · | · | · | · | · | · | · | · | |
| P/E | 32.7 | 31.5 | 34.4 | 31.2 | 34.3 | 29.2 | 35.4 | 30.9 | · | 34.0 | 27.7 | 28.8 | |
| P/S | 5.8 | 5.4 | 5.5 | 5.4 | · | · | · | · | · | · | · | · | |
| P/B | 4.8 | 4.7 | 5.0 | 5.5 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 33.0 | 26.7 | 27.9 | 26.5 | · | · | · | · | · | · | · | · | |
| P / FCF | 41.0 | 31.8 | 33.9 | 35.1 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.25% | 0.25% | 0.22% | 0.19% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.2% | 2.9% | 3.2% | 2.9% | 3.4% | 2.8% | 3.2% | · | 2.9% | 3.6% | 3.5% | |
| Payout Ratio | 9.5% | 9.2% | 8.8% | 6.5% | 5.1% | · | · | · | · | · | · | · | |
| Annual Payout | $636M | $583M | $523M | $455M | $395M | $337M | $297M | $266M | · | $237M | $238M | $241M |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.01B | $12.21B | $11.12B | $10.86B | $10.36B | $11.39B | $10.60B | $10.54B | $10.35B | $10.89B | $10.57B | $10.69B | $10.71B | $11.45B | $10.68B | $10.97B | |
| R&D Expense | $336M | $357M | $346M | $352M | $342M | $374M | $346M | $339M | $331M | $327M | $319M | $345M | $346M | $391M | $351M | $365M | |
| SG&A Expense | $2.18B | $2.35B | $2.16B | $2.14B | $2.08B | $2.20B | $2.10B | $2.11B | $2.18B | $2.13B | $2.05B | $2.15B | $2.12B | $2.30B | $2.21B | $2.21B | |
| Operating Expenses | $9.14B | $9.96B | $9.18B | $9.02B | $8.65B | $9.38B | $8.76B | $8.72B | $8.68B | $9.03B | $8.71B | $9.11B | $9.15B | $9.59B | $8.97B | $8.97B | |
| Operating Income | $1.86B | $2.25B | $1.94B | $1.83B | $1.72B | $2.02B | $1.84B | $1.82B | $1.66B | $1.85B | $1.86B | $1.58B | $1.56B | $1.86B | $1.71B | $2.00B | |
| Interest Expense | · | · | · | · | · | · | · | · | $363M | · | $359M | $326M | $300M | · | $173M | $148M | |
| Interest Income | $233M | $259M | $234M | $297M | $203M | $227M | $277M | $295M | $279M | $309M | $246M | $178M | $146M | $150M | $68M | $36M | |
| Other Non-op | $-9M | $6M | $-2M | $-19M | $3M | $13M | $-16M | $5M | $10M | $-33M | $14M | $0 | $-46M | $35M | $-4M | $28M | |
| Pretax Income | $1.73B | $2.15B | $1.83B | $1.71B | $1.62B | $1.94B | $1.74B | $1.76B | $1.59B | $1.74B | $1.76B | $1.43B | $1.36B | $1.78B | $1.60B | $1.92B | |
| Income Tax | $70M | $153M | $207M | $92M | $95M | $149M | $99M | $128M | $281M | $133M | $53M | $52M | $46M | $173M | $31M | $198M | |
| Net Income | $1.65B | $1.96B | $1.62B | $1.62B | $1.51B | $1.83B | $1.63B | $1.55B | $1.33B | $1.65B | $1.70B | $1.36B | $1.29B | $1.57B | $1.50B | $1.67B | |
| EPS (Basic) | $4.44 | $5.22 | $4.28 | $4.28 | $3.99 | $4.80 | $4.26 | $4.05 | $3.47 | $4.21 | $4.44 | $3.53 | $3.34 | $4.03 | $3.82 | $4.25 | |
| EPS (Diluted) | $4.43 | $5.21 | $4.27 | $4.28 | $3.98 | $4.78 | $4.25 | $4.04 | $3.46 | $4.20 | $4.42 | $3.51 | $3.32 | $4.01 | $3.79 | $4.22 | |
| Shares (Basic) | 372,000,000 | -757,000,000 | 378,000,000 | 378,000,000 | 378,000,000 | -764,000,000 | 382,000,000 | 382,000,000 | 382,000,000 | 0 | 386,000,000 | 386,000,000 | 386,000,000 | 0 | 392,000,000 | 392,000,000 | |
| Shares (Diluted) | 373,000,000 | -757,000,000 | 378,000,000 | 378,000,000 | 379,000,000 | -768,000,000 | 384,000,000 | 383,000,000 | 384,000,000 | 0 | 388,000,000 | 388,000,000 | 388,000,000 | -1,000,000 | 395,000,000 | 394,000,000 | |
| EBITDA | $1.86B | · | $1.94B | $1.83B | $1.72B | · | $1.84B | $1.82B | $1.66B | · | $1.86B | $1.58B | $1.56B | · | $1.71B | $2.00B |
Bilanz 26
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.25B | $9.85B | $1.98B | $4.58B | $4.13B | $4.01B | $4.64B | $7.07B | $5.50B | · | $6.15B | $3.13B | $3.48B | · | $2.92B | $1.89B | |
| Short-term Investments | $2M | $253M | $1.56B | $1.81B | $1.81B | $1.56B | $2.00B | $1.75B | $1.75B | · | · | · | · | · | · | · | |
| Receivables | $9.20B | $8.90B | $8.91B | $8.59B | $8.46B | $8.19B | $8.26B | $7.94B | $7.93B | · | $8.37B | $8.02B | $7.92B | · | $7.67B | $7.75B | |
| Inventory | $5.50B | $5.42B | $5.75B | $5.56B | $5.22B | $4.98B | $5.43B | $5.20B | $5.13B | · | $5.40B | $5.66B | $5.66B | · | $5.72B | $5.67B | |
| Other Current Assets | $2.68B | $2.61B | $2.47B | $2.60B | $2.39B | $1.96B | $1.91B | $2.02B | $1.90B | · | $1.70B | $1.72B | $1.77B | · | $1.74B | $1.65B | |
| Current Assets | $22.32B | $28.71B | $22.30B | $24.58B | $23.38B | $22.14B | $23.78B | $25.48B | $23.64B | · | $23.09B | $20.00B | $20.21B | · | $19.30B | $18.10B | |
| PP&E (Net) | $10.66B | $10.56B | $10.18B | $9.63B | $9.33B | $9.31B | $9.41B | $9.28B | $9.32B | · | $9.17B | $9.29B | $9.35B | · | $8.63B | $8.53B | |
| PP&E (Gross) | · | $18.38B | · | · | · | $16.06B | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | $7.82B | · | · | · | $6.75B | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $55.19B | $49.36B | $49.29B | $47.25B | $46.49B | $45.85B | $46.73B | $43.84B | $43.84B | $44.02B | $43.58B | $43.27B | $43.14B | $41.20B | $40.49B | $41.07B | |
| Intangibles | $19.15B | $15.84B | $16.24B | $15.15B | $15.32B | $15.53B | $16.26B | $15.52B | $16.05B | · | $17.09B | $17.44B | $17.97B | · | $17.81B | $18.58B | |
| Other Non-current Assets | $5.97B | $5.87B | $5.02B | $4.62B | $4.52B | $4.49B | $4.18B | $4.38B | $4.24B | · | $4.12B | $4.11B | $3.98B | · | $4.31B | $4.31B | |
| Total Assets | $113.28B | $110.34B | $103.02B | $101.23B | $99.04B | $97.32B | $100.36B | $98.50B | $97.09B | $98.73B | $97.06B | $94.11B | $94.66B | $97.15B | $90.54B | $90.58B | |
| Accounts Payable | $3.34B | $3.62B | $3.12B | $2.98B | $3.05B | $3.08B | $2.61B | $2.55B | $2.56B | · | $2.51B | $2.42B | $2.80B | · | $2.47B | $2.59B | |
| Current Liabilities | $14.62B | $15.19B | $14.89B | $12.72B | $13.17B | $13.33B | $14.60B | $14.77B | $13.94B | · | $14.16B | $14.11B | $15.88B | · | $11.12B | $11.00B | |
| Capital Leases | · | $1.20B | · | · | · | $1.24B | · | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $2.11B | $1.49B | $842M | $624M | $1.04B | $1.27B | $1.12B | $1.52B | $1.81B | · | $2.62B | $2.84B | $2.98B | · | $3.14B | $3.33B | |
| Other Non-current Liabilities | $4.42B | $4.27B | $4.28B | $4.27B | $3.97B | $3.99B | $4.34B | $4.39B | $4.57B | · | $4.33B | $4.04B | $4.23B | · | $4.40B | $4.53B | |
| Long-term Debt | $42.95B | $39.17B | $35.48B | $35.03B | $33.99B | $31.07B | $35.11B | $35.20B | $35.39B | · | $35.08B | $33.81B | $35.05B | · | $28.94B | $30.06B | |
| Common Stock | $445M | $445M | $445M | $444M | $444M | $444M | $444M | $443M | $443M | · | $442M | $441M | $441M | · | $440M | $440M | |
| Retained Earnings | $60.63B | $59.16B | $57.35B | $55.90B | $54.45B | $53.10B | $51.42B | $49.94B | $48.54B | · | $45.87B | $44.29B | $43.06B | · | $40.45B | $39.07B | |
| Treasury Stock | $25.36B | $22.31B | $22.31B | $21.27B | $21.27B | $19.23B | $18.23B | $18.19B | $18.19B | · | $15.12B | $15.08B | $15.08B | · | $11.01B | $10.96B | |
| AOCI | $-2.50B | $-2.45B | $-2.80B | $-2.80B | $-2.34B | $-2.70B | $-2.48B | $-2.41B | $-2.76B | · | $-3.03B | $-2.92B | $-3.05B | · | $-2.93B | $-2.72B | |
| Stockholders' Equity | $51.93B | $53.41B | $51.02B | $50.51B | $49.39B | $49.58B | $48.99B | $47.43B | $45.52B | · | $45.33B | $43.75B | $42.26B | · | $43.55B | $42.29B | |
| Liabilities + Equity | $113.28B | $110.34B | $103.02B | $101.23B | $99.04B | $97.32B | $100.36B | $98.50B | $97.09B | · | $97.06B | $94.11B | $94.66B | · | $90.54B | $90.58B | |
| Shares Outstanding | 445,000,000 | 445,000,000 | 445,000,000 | 444,000,000 | 444,000,000 | 444,000,000 | 444,000,000 | 443,000,000 | 443,000,000 | 442,000,000 | 442,000,000 | 441,000,000 | 441,000,000 | 441,000,000 | 440,000,000 | · |
Cashflow 16
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $83M | $84M | $70M | $81M | $75M | $79M | $68M | $84M | $70M | $61M | $67M | · | $76M | $75M | $77M | · | |
| Deferred Tax | $-258M | $89M | $-127M | $-322M | $-279M | $-202M | $-400M | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $430M | $436M | $435M | $430M | $429M | $438M | $449M | $514M | $551M | $563M | $584M | · | $606M | $592M | $594M | · | |
| Restructuring | $34M | $36M | $62M | $56M | $43M | $20M | $26M | $26M | $25M | $19M | $38M | · | $50M | $37M | $9M | · | |
| Operating Cash Flow | $1.19B | $3.46B | $2.24B | $1.40B | $723M | $3.29B | $2.17B | $1.96B | $1.25B | $3.72B | $2.41B | · | $729M | $3.49B | $1.94B | · | |
| CapEx | $376M | $465M | $404M | $294M | $362M | $480M | $272M | $301M | $347M | $405M | $332M | · | $458M | $550M | $547M | · | |
| Investing Cash Flow | $-8.96B | $891M | $-4.12B | $-288M | $-527M | $20M | $-3.58B | $-253M | $-2.03B | $-376M | $-1.18B | · | $-3.14B | $-525M | $-545M | · | |
| Debt Issued | $5.24B | $4.92B | $0 | $0 | $2.84B | $0 | $0 | $-1M | $1.21B | $2.48B | $3.47B | · | $0 | $3.19B | · | · | |
| Net Debt Issued | $3.83B | · | · | · | $2.00B | · | · | · | $1.21B | · | · | · | $0 | · | · | · | |
| Stock Repurchased | $3.00B | $37M | $963M | $0 | $2.00B | $1.00B | $0 | $0 | $3.00B | $0 | $0 | · | $3.00B | $1.00B | $0 | · | |
| Net Stock Activity | $-3.00B | · | · | · | $-2.00B | · | · | · | $-3.00B | · | · | · | $-3.00B | · | · | · | |
| Dividends Paid | $162M | $162M | $163M | $162M | $149M | $149M | $150M | $149M | $135M | $136M | $135M | · | $117M | $117M | $118M | · | |
| Financing Cash Flow | $1.09B | $3.53B | $-632M | $-991M | $-102M | $-3.67B | $-1.19B | $-115M | $-1.82B | $-1.43B | $1.85B | · | $-2.59B | $2.39B | $-151M | · | |
| Net Change in Cash | $-6.60B | $7.87B | $-2.59B | $431M | $132M | $-630M | $-2.43B | $1.58B | $-2.58B | $1.93B | $3.02B | · | $-5.04B | $5.60B | $1.03B | · | |
| Free Cash Flow | $816M | · | · | · | $361M | · | · | · | $904M | · | · | · | $271M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | $605M | · | · | · | $-19M | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.9% | · | 17.4% | 16.9% | 16.6% | · | 17.3% | 17.3% | 16.1% | · | 17.6% | 14.8% | 14.6% | · | 16.0% | 18.2% | |
| Net Margin | 15.0% | · | 14.5% | 14.9% | 14.6% | · | 15.4% | 14.7% | 12.9% | · | 16.0% | 12.7% | 12.1% | · | 14.0% | 15.2% | |
| Pretax Margin | 15.8% | · | 16.4% | 15.7% | 15.6% | · | 16.4% | 16.7% | 15.4% | · | 16.7% | 13.4% | 12.7% | · | 15.0% | 17.5% | |
| EBITDA Margin | 16.9% | · | 17.4% | 16.9% | 16.6% | · | 17.3% | 17.3% | 16.1% | · | 17.6% | 14.8% | 14.6% | · | 16.0% | 18.2% | |
| ROA | 1.6% | · | 1.6% | 1.6% | 1.5% | · | 1.7% | 1.6% | 1.4% | · | 1.8% | · | · | · | · | · | |
| ROE | 3.3% | · | 3.2% | 3.3% | 3.2% | · | 3.5% | 3.4% | 3.0% | · | 3.8% | · | · | · | · | · | |
| ROIC | 3.4% | · | 3.4% | 3.4% | 3.3% | · | 3.5% | 3.6% | 3.0% | · | 4.0% | · | · | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | · | 1.5 | 1.9 | 1.8 | · | 1.6 | 1.7 | 1.7 | · | 1.6 | · | · | · | · | · | |
| Quick Ratio | 0.9 | · | 0.8 | 1.2 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | 4.6 | · | 5.2 | 4.8 | 5.2 | · | 9.9 | 13.5 |
Effizienz 2
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | · | · | · | |
| Receivables Turnover | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $43.35B | · | $42.94B | $42.36B | $41.85B | · | $42.06B | $42.15B | $42.32B | · | $42.65B | $43.04B | $44.17B | · | $42.80B | $41.39B | |
| Net Income TTM | $6.39B | · | $6.37B | $6.31B | $6.02B | · | $6.20B | $5.94B | $5.68B | · | $5.85B | $5.82B | $6.68B | · | $7.29B | $7.62B | |
| Market Cap | $210.65B | · | $206.59B | $181.28B | $222.07B | · | $272.80B | $244.98B | $257.48B | · | $223.73B | · | · | · | · | · | |
| P/E | 27.9 | · | 27.7 | 24.7 | 31.8 | · | 38.0 | 35.8 | 39.5 | · | 33.7 | 35.2 | 34.0 | · | 27.5 | 28.5 | |
| P/S | 4.9 | · | 4.8 | 4.3 | 5.3 | · | 6.5 | 5.8 | 6.1 | · | 5.2 | · | · | · | · | · | |
| P/B | 4.1 | · | 4.0 | 3.6 | 4.5 | · | 5.6 | 5.2 | 5.7 | · | 4.9 | · | · | · | · | · | |
| P / Cash Flow | 176.7 | · | · | · | 307.2 | · | · | · | 205.8 | · | · | · | · | · | · | · | |
| P / FCF | 258.1 | · | · | · | 615.2 | · | · | · | 284.8 | · | · | · | · | · | · | · | |
| Earnings Yield | 3.6% | · | 3.6% | 4.0% | 3.1% | · | 2.6% | 2.8% | 2.5% | · | 3.0% | 2.8% | 2.9% | · | 3.6% | 3.5% | |
| Payout Ratio | 9.8% | · | · | · | 9.9% | · | · | · | 10.1% | · | · | · | 9.1% | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2025-03-29 | 2024-12-31 | 2024-09-28 | 2024-06-29 | |
|---|---|---|---|---|---|
| Umsatz | $44.56B | — | $42.88B | — | — |
| Betriebsgewinnmarge % | 17.4% | — | 17.1% | — | — |
| Nettoergebnis | $6.70B | — | $6.33B | — | — |
| Verwässerte EPS | $17.74 | — | $16.53 | — | — |
Bilanz
| 2025-12-31 | 2025-03-29 | 2024-12-31 | 2024-09-28 | 2024-06-29 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.9 | — | 1.7 | — | — |
| Quick Ratio | 1.3 | — | 1.0 | — | — |
Cashflow
| 2025-12-31 | 2025-03-29 | 2024-12-31 | 2024-09-28 | 2024-06-29 | |
|---|---|---|---|---|---|
| Freier Cashflow | $6.29B | — | $7.27B | — | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- Mögen Wall Street Analysten Thermo Fisher Scientific Aktien?
- Thermo Fisher Scientific Inc. (TMO) enthüllt Bioprozess-Designzentrum zur Entwicklung lebensverändernder Therapien
- Jim Cramer über Thermo Fisher: „Ich denke, Sie können es bei diesem Kurs kaufen“
- TD Cowen Senkt das Kursziel für Thermo Fisher (TMO), behält Kaufempfehlung bei
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.